Observational
Answers are grounded in this paper and cite their sources.
SMI may refine risk stratification in asymptomatic diabetes; leaves open whether microvascular dysfunction drives prognosis in normal coronaries.
Silent myocardial ischemia (SMI) is common in patients with diabetes (1–4). The prognostic value of SMI, evidenced by exercise electrocardiogram (ECG) stress test (5) and thallium 201 myocardial scintigraphy (6), as well as their association (7) in asymptomatic diabetic patients, has recently been demonstrated. About 50% of the patients with SMI exhibit angiographically normal coronary arteries (1,2). In these patients, endothelial dysfunction and abnormalities of coronary microcirculation may be involved (8). So far, the respective roles played by these functional disorders, by the demonstrated silent coronary stenoses, or by both in the poor prognosis of SMI are still unknown.
No takes yet. Share an insight, caveat, or question.
Cosson et al. (2003) conducted an observational in Diabetes and silent myocardial ischemia. Coronary stenoses was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: